openPR Logo
Press release

Investigation announced for Investors in shares of Inari Medical, Inc. (NASDAQ: NARI) Investor over potential Wrongdoing

An investigation on behalf of investors in Inari Medical, Inc. (NASDAQ: NARI) shares over potential wrongdoing at Inari Medical.

An investigation on behalf of investors in Inari Medical, Inc. (NASDAQ: NARI) shares over potential wrongdoing at Inari Medical.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Inari Medical, Inc. .

Investors who purchased shares of Inari Medical, Inc. (NASDAQ: NARI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Inari Medical, Inc.and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Irvine, CA based Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. Inari Medical, Inc. reported that its annual Total Revenue rose from $383.47 million in 2022 to $493.63 million in 2023, and that its Net Loss declined from $29.26 million in 2022 to $1.63 million in 2023.

On February 28, 2024, after market hours, Inari Medical filed an Annual Report on Form 10-K with the SEC announcing "[i]n December 2023, we received a civil investigative demand ("CID") from the U.S. Department of Justice, Civil Division, in connection with an investigation under the federal Anti-Kickback Statute and Civil False Claims Act (the "Investigation"). The CID requests information and documents primarily relating to meals and consulting service payments provided to health care professionals ("HCPs"). We are cooperating with the Investigation. We are unable to express a view at this time regarding the likely duration, or ultimate outcome, of the Investigation or estimate the possibility of, or amount or range of, any possible financial impact. Depending on the outcome of the Investigation, there may be a material impact on our business, results of operations, or financial condition."

Shares of Inari Medical, Inc. (NASDAQ: NARI) declined from $67.10 per share on December 19, 2023, to as low as $40.81 per share on March 05, 2023.

Those who purchased shares of Inari Medical, Inc. (NASDAQ: NARI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Inari Medical, Inc. (NASDAQ: NARI) Investor over potential Wrongdoing here

News-ID: 3481259 • Views:

More Releases from Shareholders Foundation, Inc.

Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potential Wrongdoing
Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potentia …
An investigation on behalf of current long-term investors in shares of Novo Nordisk A/S (NYSE: NVO) concerning potential breaches of fiduciary duties by certain directors and officers was announced. Investors who are current long term investors in Novo Nordisk A/S (NYSE: NVO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for long term investors in
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ: FTNT)
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ …
An investor, who purchased shares of Fortinet, Inc. (NASDAQ: FTNT), filed a lawsuit over alleged violations of Federal Securities Laws by Fortinet, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fortinet, Inc. (NASDAQ: FTNT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2025. NASDAQ: FTNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on October 07, 2025
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on Octob …
A deadline is coming up on October 07, 2025in the lawsuit filed for certain investors of CTO Realty Growth, Inc. (NYSE: CTO) over alleged securities laws violations by CTO Realty Growth, Inc. Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and there are strict and short deadlines running. Deadline: October 07, 2025. CTO Realty Growth, Inc. (NYSE: CTO) stockholders should contact the Shareholders Foundation at
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR)
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeu …
An investor, who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR), filed a lawsuit over alleged violations of Federal Securities Laws by Jasper Therapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Inari

Lawsuit filed for Investors who lost money with shares of Inari Medical, Inc. (N …
An investor, who purchased shares of Inari Medical, Inc. (NASDAQ: NARI), filed a lawsuit over alleged violations of Federal Securities Laws by Inari Medical, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Inari Medical, Inc. (NASDAQ: NARI) have certain options and for certain investors are short and strict deadlines running. Deadline: July 12, 2024. NASDAQ: NARI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Investigation announced for Investors who lost money with shares of Inari Medica …
An investigation was announced over potential securities laws violations by Inari Medical, Inc. in connection with certain financial statements. Investors who purchased shares of Inari Medical, Inc. (NASDAQ: NARI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether certain statements by Inari Medical, Inc. regarding its business, its prospects and its operations were materially false
Global Mechanical Thrombectomy Devices Market is poised to witness a 6% CAGR by …
Blood clots are a common health concern which needs an immediate medical attention. Mechanical thrombectomy devices are used in medical procedures used to treat arterial blockages caused by blood clots. The conditions which are treatable by a mechanical thrombectomy are ischemic stroke, pulmonary embolism (PE), and deep vein thrombosis (DVT). Technological Innovations and Developments in Mechanical Thrombectomy Triggers the Growth of Mechanical Thrombectomy Devices Market The global mechanical thrombectomy devices market is
Catheter-Directed Thrombolysis Market (2023-2030) Comprehensive Review With Tren …
The most recent expert intelligence report from WMR, titled "The Global Catheter-Directed Thrombolysis Market 2023: Growing Need and Opportunities" offers a sorted view of the Catheter-Directed Thrombolysis industry through an analysis of research and data gathered from various sources. This information can assist global market decision-makers in playing a significant role in having a gradual impact on the global economy. In terms of market size, market statistics, and competitive environment,
Ultrasonic Thrombectomy Device Market Growth Opportunity And Forecast 2029| Stry …
Los Angeles, United State: QY Research recently published a research report titled, "Global Ultrasonic Thrombectomy Device Research Report Market 2023". The research study presented in this report offers complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global Ultrasonic Thrombectomy Device market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global
Thrombus Management Device Market Size, Historical Growth, Analysis, Opportuniti …
LOS ANGELES, United States: The report named "Global Thrombus Management Device Market Insights, Forecast to 2028", is added to the archive of market research studies of QY Research. The report offers extensive study of the global Thrombus Management Device market pertaining to the key opportunities and drivers that are influencing the market growth. Key emerging trends and their impact on the present as well as upcoming market developments are also